ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE was reported 1930 times

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEVER HALLUCINATIONS 1 0.2500
1 STOMA SITE DERMATITIS 5 0.1515
2 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 36 0.0822
3 HEAT CRAMPS 1 0.0769
4 ANOPLASTY 1 0.0769
5 OBSTRUCTIVE DEFAECATION 5 0.0746
6 CARDIAC VENTRICULAR SCARRING 1 0.0667
7 REACTION TO FOOD COLOURING 1 0.0400
8 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 1 0.0400
9 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 5 0.0345
10 EXPOSURE KERATITIS 1 0.0333
11 ACUTE HAEMORRHAGIC CONJUNCTIVITIS 1 0.0333
12 BURKHOLDERIA TEST POSITIVE 4 0.0323
13 DUCHENNE MUSCULAR DYSTROPHY 3 0.0323
14 EXANTHEMA SUBITUM 1 0.0294
15 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 4 0.0290
16 PLACENTAL HYPERTROPHY 1 0.0250
17 GLUTATHIONE DECREASED 1 0.0238
18 PHENYLKETONURIA 1 0.0222
19 ECZEMA INFANTILE 2 0.0208
20 CRANIOPLASTY 1 0.0200
21 PELVIC MISALIGNMENT 1 0.0196
22 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 132 0.0184
23 STEM CELL THERAPY 1 0.0169
24 ADMINISTRATION SITE SCAR 1 0.0161
25 LABIA ENLARGED 1 0.0159
26 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 96 0.0158
27 VASODILATION PROCEDURE 1 0.0147
28 CONJUNCTIVAL SCAR 2 0.0132
29 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 88 0.0129
30 SUSPECTED PRODUCT CONTAMINATION 13 0.0128
31 ROSEOLA 1 0.0123
32 VAGAL NERVE STIMULATOR IMPLANTATION 3 0.0098
33 VESTIBULAR NEURONITIS 5 0.0094
34 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
35 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
36 PERIPORTAL OEDEMA 1 0.0080
37 BREATH HOLDING 3 0.0078
38 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
39 SHORT STATURE 2 0.0076
40 CHEMICAL BURN OF GASTROINTESTINAL TRACT 1 0.0073
41 ENTEROBIASIS 1 0.0067
42 STOMA SITE INFLAMMATION 5 0.0067
43 HISTRIONIC PERSONALITY DISORDER 1 0.0066
44 BILIARY FISTULA 1 0.0065
45 NEONATAL TACHYCARDIA 1 0.0065
46 ACUTE TONSILLITIS 1 0.0063
47 TRICHIASIS 2 0.0063
48 URINARY RETENTION POSTOPERATIVE 1 0.0061
49 REACTION TO AZO-DYES 1 0.0058
50 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
51 COMA HEPATIC 4 0.0054
52 ADENOIDECTOMY 2 0.0052
53 EXPOSURE TO UNSPECIFIED AGENT 1 0.0051
54 EXSANGUINATION 1 0.0050
55 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0047
56 EXTRASKELETAL OSSIFICATION 1 0.0047
57 STUBBORNNESS 2 0.0046
58 SENSORY LEVEL ABNORMAL 1 0.0044
59 GASTROINTESTINAL STOMA OUTPUT INCREASED 2 0.0043
60 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
61 HELMINTHIC INFECTION 1 0.0041
62 HYPERDYNAMIC LEFT VENTRICLE 1 0.0041
63 PRODUCT PACKAGING ISSUE 38 0.0040
64 CORNEAL THINNING 1 0.0039
65 INFANTILE SPITTING UP 2 0.0038
66 EAR INFECTION BACTERIAL 1 0.0037
67 PRODUCT CONTAMINATION PHYSICAL 9 0.0035
68 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
69 STOMA SITE PAIN 5 0.0034
70 TEETHING 1 0.0033
71 URETHRAL HAEMORRHAGE 2 0.0033
72 CORNEA VERTICILLATA 1 0.0033
73 NEURITIS 5 0.0032
74 POST PROCEDURAL BILE LEAK 1 0.0032
75 GASTROINTESTINAL STOMA COMPLICATION 5 0.0032
76 CEREBRAL PALSY 3 0.0032
77 PRODUCT PACKAGE ASSOCIATED INJURY 7 0.0031
78 WRONG DRUG ADMINISTERED 27 0.0030
79 SALIVA DISCOLOURATION 1 0.0030
80 AMINO ACID LEVEL DECREASED 1 0.0030
81 SPORTS INJURY 1 0.0029
82 VERTIGO POSITIONAL 5 0.0029
83 GLOBULINS INCREASED 1 0.0027
84 ANASTOMOTIC STENOSIS 1 0.0027
85 NASAL TURBINATE HYPERTROPHY 1 0.0027
86 ADENOIDAL HYPERTROPHY 1 0.0026
87 NEUROBLASTOMA 1 0.0026
88 CONVULSIVE THRESHOLD LOWERED 1 0.0025
89 PRODUCT DROPPER ISSUE 2 0.0025
90 CROUP INFECTIOUS 2 0.0025
91 UNDERWEIGHT 5 0.0025
92 BONE DENSITY INCREASED 1 0.0025
93 OTITIS EXTERNA 3 0.0025
94 ANHIDROSIS 1 0.0025
95 REACTION TO COLOURING 1 0.0024
96 SEIZURE CLUSTER 2 0.0024
97 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 3 0.0024
98 OTITIS MEDIA CHRONIC 1 0.0024
99 BELLIGERENCE 1 0.0023
100 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
101 WRONG PATIENT RECEIVED MEDICATION 6 0.0022
102 PATIENT UNCOOPERATIVE 1 0.0021
103 DRUG ADMINISTRATION ERROR 64 0.0021
104 EAR INJURY 1 0.0020
105 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
106 AUTISM SPECTRUM DISORDER 11 0.0020
107 PRODUCT DIFFICULT TO SWALLOW 2 0.0020
108 ACCIDENTAL DRUG INTAKE BY CHILD 3 0.0020
109 GLARE 1 0.0019
110 POSTURING 1 0.0019
111 SKIN CANDIDA 1 0.0019
112 PRODUCT SELECTION ERROR 2 0.0018
113 PRODUCT CLOSURE ISSUE 1 0.0018
114 HEPATORENAL SYNDROME 3 0.0018
115 EXPIRED PRODUCT ADMINISTERED 59 0.0018
116 PRODUCT LABEL ISSUE 12 0.0018
117 SLEEP TALKING 3 0.0018
118 SINUS POLYP 1 0.0017
119 METAL POISONING 1 0.0017
120 PRODUCT CONTAMINATION 6 0.0017
121 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
122 GINGIVAL HYPERPLASIA 1 0.0017
123 CATARACT SUBCAPSULAR 1 0.0016
124 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
125 HYPERCHLORAEMIA 1 0.0016
126 IATROGENIC INJURY 2 0.0016
127 REFLEXES ABNORMAL 1 0.0015
128 WRONG DEVICE USED 1 0.0015
129 BONE DEFORMITY 1 0.0015
130 NASAL DISCHARGE DISCOLOURATION 2 0.0014
131 BILIARY TRACT DISORDER 2 0.0014
132 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
133 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
134 DERMATITIS DIAPER 1 0.0014
135 THYROXINE INCREASED 1 0.0014
136 EXTRA DOSE ADMINISTERED 57 0.0014
137 SYMPTOM MASKED 1 0.0014
138 GROWTH RETARDATION 4 0.0014
139 PRODUCT LOT NUMBER ISSUE 3 0.0014
140 KNEE DEFORMITY 2 0.0013
141 AMINO ACID LEVEL INCREASED 1 0.0013
142 TRACHEITIS 1 0.0013
143 COMPRESSION FRACTURE 7 0.0013
144 LIMB ASYMMETRY 1 0.0013
145 FAECES HARD 5 0.0013
146 GRIMACING 1 0.0013
147 MUSCLE DISCOMFORT 1 0.0013
148 INAPPROPRIATE AFFECT 2 0.0013
149 VITAMIN B12 INCREASED 1 0.0013
150 SKIN BACTERIAL INFECTION 1 0.0012
151 STARING 3 0.0012
152 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
153 GASTROENTERITIS SALMONELLA 1 0.0012
154 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1 0.0012
155 RECALLED PRODUCT 2 0.0012
156 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
157 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
158 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
159 BEHAVIOUR DISORDER 6 0.0011
160 PROTEIN URINE 1 0.0011
161 LIVER TRANSPLANT 4 0.0011
162 LUMBAR VERTEBRAL FRACTURE 5 0.0011
163 PUNCTATE KERATITIS 1 0.0011
164 BIOPSY 1 0.0011
165 ACCIDENTAL OVERDOSE 39 0.0011
166 TRAUMATIC HAEMORRHAGE 2 0.0011
167 KLEBSIELLA BACTERAEMIA 1 0.0011
168 BLOOD URINE 1 0.0010
169 STRABISMUS 3 0.0010
170 MASTOIDITIS 1 0.0010
171 HAEMOPHILUS INFECTION 1 0.0010
172 TOOTH DISCOLOURATION 3 0.0010
173 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
174 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
175 HYPOCHROMIC ANAEMIA 1 0.0010
176 RETCHING 21 0.0010
177 PRODUCT COLOUR ISSUE 5 0.0010
178 ANAL PRURITUS 2 0.0010
179 PERTUSSIS 1 0.0010
180 THYROID HORMONES INCREASED 1 0.0010
181 ACUTE HEPATIC FAILURE 13 0.0010
182 SCREAMING 6 0.0009
183 PRODUCT PHYSICAL ISSUE 19 0.0009
184 PRODUCT COMMINGLING 1 0.0009
185 PRODUCT CONTAINER ISSUE 8 0.0009
186 REACTION TO DRUG EXCIPIENTS 2 0.0009
187 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
188 EAR INFECTION 24 0.0009
189 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
190 CORTISOL DECREASED 1 0.0009
191 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
192 REGURGITATION 3 0.0009
193 LIP ULCERATION 1 0.0009
194 NEPHROCALCINOSIS 1 0.0008
195 PNEUMONIA INFLUENZAL 1 0.0008
196 DRUG PRESCRIBING ERROR 16 0.0008
197 CHRONIC RESPIRATORY FAILURE 1 0.0008
198 BREATH ODOUR 2 0.0008
199 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
200 PRODUCT TASTE ABNORMAL 11 0.0008
201 HEPATIC NECROSIS 3 0.0008
202 LIP DISCOLOURATION 1 0.0008
203 TESTICULAR SWELLING 1 0.0008
204 POOR QUALITY DRUG ADMINISTERED 5 0.0008
205 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
206 PRODUCT FORMULATION ISSUE 5 0.0008
207 OESOPHAGEAL HAEMORRHAGE 1 0.0008
208 WRONG PRODUCT ADMINISTERED 5 0.0007
209 ACCIDENTAL POISONING 1 0.0007
210 DEFAECATION URGENCY 5 0.0007
211 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
212 SLEEP TERROR 3 0.0007
213 CATAPLEXY 1 0.0007
214 NOROVIRUS INFECTION 1 0.0007
215 OCULAR ICTERUS 3 0.0007
216 VOMITING PROJECTILE 2 0.0007
217 HYPOTHERMIA 7 0.0007
218 ACCIDENTAL EXPOSURE TO PRODUCT 71 0.0007
219 MUTISM 1 0.0007
220 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
221 ANKLE OPERATION 1 0.0007
222 HEPATITIS FULMINANT 2 0.0007
223 IMPETIGO 1 0.0007
224 GASTRITIS HAEMORRHAGIC 1 0.0007
225 GASTROENTERITIS VIRAL 12 0.0007
226 HYPERSOMNIA 19 0.0007
227 VASCULAR DEVICE INFECTION 3 0.0007
228 PALLIATIVE CARE 1 0.0007
229 ORAL MUCOSAL ERYTHEMA 1 0.0006
230 PRODUCT DEPOSIT 1 0.0006
231 YELLOW SKIN 3 0.0006
232 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
233 CUSHINGOID 2 0.0006
234 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 125 0.0006
235 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
236 HICCUPS 5 0.0006
237 EXPOSURE DURING BREAST FEEDING 2 0.0006
238 VEIN RUPTURE 1 0.0006
239 TONSILLAR HYPERTROPHY 1 0.0006
240 LEUKAEMIA RECURRENT 1 0.0006
241 EROSIVE OESOPHAGITIS 1 0.0006
242 RETINITIS 1 0.0006
243 PRODUCT ODOUR ABNORMAL 6 0.0006
244 PRODUCT USE ISSUE 107 0.0006
245 PRODUCT TAMPERING 1 0.0006
246 LIVER TRANSPLANT REJECTION 1 0.0006
247 OBSESSIVE THOUGHTS 1 0.0006
248 PHARYNGITIS STREPTOCOCCAL 6 0.0006
249 NASAL OEDEMA 1 0.0006
250 CONDUCTION DISORDER 1 0.0005
251 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
252 STREPTOCOCCAL INFECTION 3 0.0005
253 INCORRECT DOSE ADMINISTERED 123 0.0005
254 JAUNDICE NEONATAL 1 0.0005
255 BONE MARROW TRANSPLANT 1 0.0005
256 MECHANICAL VENTILATION 1 0.0005
257 HYPOREFLEXIA 1 0.0005
258 MOTION SICKNESS 1 0.0005
259 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
260 COLOSTOMY 1 0.0005
261 REBOUND ATOPIC DERMATITIS 1 0.0005
262 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
263 CRYING 18 0.0005
264 COAGULOPATHY 8 0.0005
265 WEIGHT FLUCTUATION 5 0.0005
266 LUNG ABSCESS 1 0.0005
267 HALLUCINATIONS, MIXED 2 0.0005
268 SLEEP DEFICIT 1 0.0005
269 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
270 GASTRIC BYPASS 1 0.0005
271 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
272 ABNORMAL BEHAVIOUR 18 0.0005
273 WHEELCHAIR USER 2 0.0004
274 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 32 0.0004
275 TEMPERATURE REGULATION DISORDER 1 0.0004
276 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
277 HEPATOCELLULAR DAMAGE 1 0.0004
278 DRUG EFFECT DELAYED 2 0.0004
279 BRAIN OPERATION 1 0.0004
280 EAR DISORDER 2 0.0004
281 DROOLING 3 0.0004
282 REACTION TO EXCIPIENT 1 0.0004
283 INFUSION SITE INFECTION 1 0.0004
284 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
285 ESCHERICHIA BACTERAEMIA 1 0.0004
286 LACERATION 4 0.0004
287 VOLVULUS 1 0.0004
288 SINUS OPERATION 1 0.0004
289 INCREASED APPETITE 8 0.0004
290 VARICELLA 1 0.0004
291 WEIGHT ABNORMAL 1 0.0004
292 HUMERUS FRACTURE 2 0.0004
293 PAINFUL RESPIRATION 1 0.0004
294 DRUG EFFECT INCOMPLETE 15 0.0004
295 LYMPHADENITIS 1 0.0004
296 THERAPY CHANGE 4 0.0004
297 BODY TEMPERATURE DECREASED 4 0.0004
298 GASTROINTESTINAL TUBE INSERTION 1 0.0004
299 HYPERAMMONAEMIA 2 0.0004
300 FLUID INTAKE REDUCED 2 0.0004
301 CATHETER SITE HAEMORRHAGE 1 0.0004
302 URINARY TRACT INFECTION BACTERIAL 1 0.0004
303 HOSTILITY 1 0.0004
304 PETIT MAL EPILEPSY 2 0.0004
305 MENOPAUSE 1 0.0004
306 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
307 CATHETER SITE PAIN 1 0.0004
308 HERNIA REPAIR 1 0.0004
309 PARTIAL SEIZURES 2 0.0004
310 PERSONALITY DISORDER 1 0.0004
311 CYANOSIS 6 0.0004
312 PRODUCT USE COMPLAINT 6 0.0004
313 LUNG OPACITY 1 0.0004
314 JOINT DISLOCATION 4 0.0004
315 ANGIONEUROTIC OEDEMA 1 0.0004
316 BLOOD POTASSIUM ABNORMAL 1 0.0004
317 SEIZURE 43 0.0004
318 FRUSTRATION TOLERANCE DECREASED 3 0.0004
319 BLOOD PHOSPHORUS INCREASED 1 0.0004
320 JAW DISORDER 2 0.0004
321 ULCERATIVE KERATITIS 1 0.0004
322 SPINAL COMPRESSION FRACTURE 3 0.0004
323 EOSINOPHILIC OESOPHAGITIS 1 0.0004
324 VIRAL INFECTION 12 0.0004
325 INTENTIONAL PRODUCT MISUSE 31 0.0004
326 PRODUCT ADMINISTRATION ERROR 7 0.0003
327 PRODUCT QUALITY ISSUE 47 0.0003
328 HYPERVENTILATION 2 0.0003
329 BODY TEMPERATURE INCREASED 7 0.0003
330 SYRINGE ISSUE 6 0.0003
331 APATHY 5 0.0003
332 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
333 NEGATIVE THOUGHTS 1 0.0003
334 URINE ANALYSIS ABNORMAL 1 0.0003
335 BLOOD CULTURE POSITIVE 1 0.0003
336 METABOLIC ENCEPHALOPATHY 1 0.0003
337 OROPHARYNGEAL DISCOMFORT 3 0.0003
338 TYPE 1 DIABETES MELLITUS 2 0.0003
339 CENTRAL VENOUS CATHETERISATION 1 0.0003
340 EMERGENCY CARE 1 0.0003
341 ADRENAL INSUFFICIENCY 4 0.0003
342 MASTICATION DISORDER 1 0.0003
343 HEPATIC ENZYME INCREASED 22 0.0003
344 INFUSION SITE EXTRAVASATION 2 0.0003
345 BLOOD CREATININE DECREASED 1 0.0003
346 BRAIN FOG 5 0.0003
347 INFUSION SITE SWELLING 2 0.0003
348 FOREIGN BODY IN THROAT 1 0.0003
349 STEVENS-JOHNSON SYNDROME 7 0.0003
350 VOMITING 148 0.0003
351 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
352 ERUCTATION 6 0.0003
353 HEPATITIS ACUTE 2 0.0003
354 POSTURE ABNORMAL 1 0.0003
355 SOMNAMBULISM 2 0.0003
356 INCORRECT PRODUCT STORAGE 4 0.0003
357 OTITIS MEDIA 1 0.0003
358 APPETITE DISORDER 2 0.0003
359 SPINAL FRACTURE 6 0.0003
360 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
361 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
362 BLOOD CREATININE ABNORMAL 1 0.0003
363 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
364 BRONCHIOLITIS 1 0.0003
365 LOGORRHOEA 1 0.0003
366 FACIAL PARESIS 1 0.0003
367 PRODUCT SUPPLY ISSUE 2 0.0003
368 DEVICE KINK 1 0.0003
369 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
370 BLOOD PHOSPHORUS DECREASED 1 0.0003
371 VENTRICULAR ARRHYTHMIA 1 0.0003
372 FOOD INTOLERANCE 1 0.0003
373 RASH GENERALISED 7 0.0003
374 MEDICATION ERROR 15 0.0003
375 MALNUTRITION 3 0.0003
376 THROAT CLEARING 1 0.0003
377 IMPULSIVE BEHAVIOUR 1 0.0003
378 CHRONIC SINUSITIS 1 0.0003
379 PARANASAL SINUS DISCOMFORT 1 0.0003
380 FACE INJURY 1 0.0003
381 GASTRIC INFECTION 1 0.0003
382 CLAVICLE FRACTURE 1 0.0003
383 PHARYNGEAL OEDEMA 4 0.0003
384 FREQUENT BOWEL MOVEMENTS 7 0.0003
385 FOOD ALLERGY 2 0.0003
386 CONCUSSION 2 0.0003
387 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
388 RHINOVIRUS INFECTION 1 0.0003
389 WOUND SECRETION 1 0.0003
390 MOOD SWINGS 8 0.0003
391 SKIN PAPILLOMA 1 0.0002
392 ENURESIS 1 0.0002
393 FEEDING DISORDER 5 0.0002
394 SELF-MEDICATION 1 0.0002
395 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
396 ANGER 8 0.0002
397 THROAT CANCER 1 0.0002
398 HYPERPYREXIA 1 0.0002
399 POOR PERIPHERAL CIRCULATION 1 0.0002
400 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
401 TEARFULNESS 1 0.0002
402 NIGHTMARE 8 0.0002
403 PARONYCHIA 1 0.0002
404 EMOTIONAL DISORDER 7 0.0002
405 GINGIVAL SWELLING 1 0.0002
406 LETHARGY 13 0.0002
407 FACIAL PAIN 2 0.0002
408 THROAT IRRITATION 10 0.0002
409 ANAL INCONTINENCE 2 0.0002
410 DEVELOPMENTAL DELAY 2 0.0002
411 OFF LABEL USE 190 0.0002
412 EYE SWELLING 8 0.0002
413 MASS 3 0.0002
414 ROSACEA 1 0.0002
415 BACTERIAL INFECTION 4 0.0002
416 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
417 BLINDNESS UNILATERAL 3 0.0002
418 SKIN ABRASION 1 0.0002
419 HYPOVOLAEMIC SHOCK 1 0.0002
420 EYE PRURITUS 7 0.0002
421 VULVOVAGINAL PAIN 1 0.0002
422 ATELECTASIS 2 0.0002
423 PRESCRIBED OVERDOSE 4 0.0002
424 FINGER DEFORMITY 1 0.0002
425 RENAL TUBULAR NECROSIS 2 0.0002
426 LIVER INJURY 5 0.0002
427 ENCEPHALOPATHY 5 0.0002
428 HOSPICE CARE 2 0.0002
429 SKIN HAEMORRHAGE 3 0.0002
430 HYPERVOLAEMIA 1 0.0002
431 UPPER LIMB FRACTURE 4 0.0002
432 HYPERNATRAEMIA 1 0.0002
433 HEPATIC ENZYME ABNORMAL 1 0.0002
434 HEPATIC FAILURE 6 0.0002
435 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
436 DRUG DISPENSING ERROR 3 0.0002
437 AMMONIA INCREASED 1 0.0002
438 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
439 FLATULENCE 11 0.0002
440 SKIN NECROSIS 1 0.0002
441 PERIORBITAL OEDEMA 1 0.0002
442 RESPIRATORY TRACT INFECTION 5 0.0002
443 SCRATCH 2 0.0002
444 HALLUCINATION, VISUAL 4 0.0002
445 PNEUMOTHORAX 3 0.0002
446 FEAR 5 0.0002
447 PYREXIA 64 0.0002
448 CHEILITIS 1 0.0002
449 FAECES DISCOLOURED 4 0.0002
450 ILLNESS 19 0.0002
451 SKIN LACERATION 2 0.0002
452 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
453 PALLOR 5 0.0002
454 TIC 1 0.0002
455 IRRITABILITY 11 0.0002
456 ASPIRATION 2 0.0002
457 FAECALOMA 1 0.0002
458 ASTHENOPIA 1 0.0002
459 CHOKING SENSATION 1 0.0002
460 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
461 TRANSAMINASES INCREASED 4 0.0002
462 AGGRESSION 9 0.0002
463 RASH MACULO-PAPULAR 4 0.0002
464 INTRACRANIAL PRESSURE INCREASED 1 0.0002
465 STATUS EPILEPTICUS 2 0.0002
466 PERIORBITAL SWELLING 1 0.0002
467 GENERALISED ERYTHEMA 1 0.0002
468 INTENTIONAL DOSE OMISSION 5 0.0002
469 GASTRIC HAEMORRHAGE 2 0.0002
470 MUSCLE TWITCHING 4 0.0002
471 MOUTH SWELLING 1 0.0002
472 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
473 PRODUCT LABEL CONFUSION 1 0.0002
474 DERMATITIS ATOPIC 9 0.0002
475 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
476 COLD SWEAT 3 0.0002
477 BRADYKINESIA 1 0.0002
478 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
479 URINARY INCONTINENCE 5 0.0002
480 LEUKOCYTOSIS 3 0.0002
481 VULVOVAGINAL BURNING SENSATION 1 0.0002
482 PIGMENTATION DISORDER 1 0.0002
483 SCOLIOSIS 1 0.0002
484 INFLUENZA 18 0.0002
485 CHOLANGITIS 1 0.0002
486 URTICARIA 27 0.0002
487 PNEUMONIA ASPIRATION 4 0.0002
488 INTESTINAL OBSTRUCTION 6 0.0002
489 HYPOPHAGIA 4 0.0002
490 ACUTE RESPIRATORY FAILURE 3 0.0002
491 NIGHT SWEATS 5 0.0002
492 RHINORRHOEA 10 0.0002
493 INCOHERENT 1 0.0002
494 PRODUCT PREPARATION ISSUE 1 0.0002
495 SARS-COV-2 TEST POSITIVE 2 0.0002
496 JAUNDICE 4 0.0001
497 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
498 POSTOPERATIVE WOUND INFECTION 1 0.0001
499 SINUS CONGESTION 2 0.0001
500 IMPAIRED GASTRIC EMPTYING 2 0.0001
501 MOOD ALTERED 4 0.0001
502 SINUSITIS 15 0.0001
503 COUGH 41 0.0001
504 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
505 RESPIRATION ABNORMAL 1 0.0001
506 ENCEPHALITIS 1 0.0001
507 HAIR GROWTH ABNORMAL 1 0.0001
508 AUTOIMMUNE HEPATITIS 1 0.0001
509 RASH MACULAR 5 0.0001
510 MOUTH ULCERATION 3 0.0001
511 SKIN REACTION 2 0.0001
512 PAPULE 1 0.0001
513 SEASONAL ALLERGY 2 0.0001
514 THERMAL BURN 1 0.0001
515 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
516 FEAR OF INJECTION 1 0.0001
517 OVERDOSE 30 0.0001
518 PANIC REACTION 1 0.0001
519 FAECES SOFT 1 0.0001
520 INTENTIONAL UNDERDOSE 1 0.0001
521 SURGERY 8 0.0001
522 NASAL CONGESTION 8 0.0001
523 ARTHROPOD BITE 1 0.0001
524 ECZEMA 7 0.0001
525 SNEEZING 3 0.0001
526 HYDRONEPHROSIS 1 0.0001
527 CHROMATURIA 3 0.0001
528 PRODUCT DOSE OMISSION ISSUE 39 0.0001
529 ACIDOSIS 1 0.0001
530 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
531 CONGENITAL ANOMALY 1 0.0001
532 MULTIPLE ALLERGIES 1 0.0001
533 BALANCE DISORDER 11 0.0001
534 HEAD INJURY 4 0.0001
535 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
536 TRICUSPID VALVE INCOMPETENCE 1 0.0001
537 RASH ERYTHEMATOUS 6 0.0001
538 BLOOD DISORDER 1 0.0001
539 CONTUSION 12 0.0001
540 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
541 SENSORY LOSS 1 0.0001
542 HYPOGLYCAEMIA 6 0.0001
543 UNDERDOSE 9 0.0001
544 SHOCK HAEMORRHAGIC 1 0.0001
545 CONVULSION 7 0.0001
546 ABNORMAL FAECES 1 0.0001
547 HYPERAESTHESIA 1 0.0001
548 EYE DISORDER 4 0.0001
549 ABDOMINAL PAIN UPPER 25 0.0001
550 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
551 WEIGHT INCREASED 27 0.0001
552 DECREASED APPETITE 28 0.0001
553 ABDOMINAL DISCOMFORT 20 0.0001
554 HAEMODIALYSIS 1 0.0001
555 INFUSION SITE ERYTHEMA 1 0.0001
556 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
557 HEPATITIS 3 0.0001
558 VITAMIN D DECREASED 1 0.0001
559 SCAR 2 0.0001
560 ANURIA 1 0.0001
561 BLOOD MAGNESIUM DECREASED 1 0.0001
562 MUSCLE STRAIN 1 0.0001
563 DEVICE LEAKAGE 5 0.0001
564 SKIN SWELLING 1 0.0001
565 SEDATION 3 0.0001
566 URINE OUTPUT DECREASED 1 0.0001
567 GROIN PAIN 1 0.0001
568 HYPOXIA 4 0.0001
569 LUNG INFILTRATION 1 0.0001
570 HYPERSENSITIVITY 21 0.0001
571 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
572 GASTROINTESTINAL INFECTION 1 0.0001
573 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
574 THROAT TIGHTNESS 3 0.0001
575 RESTLESS LEGS SYNDROME 2 0.0001
576 PNEUMONIA BACTERIAL 1 0.0001
577 BRAIN NEOPLASM 1 0.0001
578 RESPIRATORY ARREST 3 0.0001
579 INCREASED TENDENCY TO BRUISE 1 0.0001
580 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
581 IRON DEFICIENCY ANAEMIA 1 0.0001
582 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
583 PRODUCT DISTRIBUTION ISSUE 1 0.0001
584 CONJUNCTIVITIS 2 0.0001
585 DYSGEUSIA 8 0.0001
586 PERSONALITY CHANGE 1 0.0001
587 THINKING ABNORMAL 2 0.0001
588 HEPATIC ENCEPHALOPATHY 1 0.0001
589 MIDDLE INSOMNIA 2 0.0001
590 APPENDICITIS 1 0.0001
591 DIARRHOEA HAEMORRHAGIC 1 0.0001
592 PHOTOPHOBIA 2 0.0001
593 HALLUCINATION 8 0.0001
594 RECALLED PRODUCT ADMINISTERED 1 0.0001
595 AFFECT LABILITY 1 0.0001
596 DYSSTASIA 3 0.0001
597 PARKINSONISM 1 0.0001
598 TREMOR 17 0.0001
599 SKIN FISSURES 2 0.0001
600 PHARYNGEAL SWELLING 1 0.0001
601 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
602 HEPATOMEGALY 1 0.0001
603 PRESCRIBED UNDERDOSE 2 0.0001
604 INTENTIONAL SELF-INJURY 2 0.0001
605 STOMATITIS 6 0.0001
606 DYSKINESIA 4 0.0001
607 EYELID PTOSIS 1 0.0001
608 DRY THROAT 1 0.0001
609 SLUGGISHNESS 1 0.0001
610 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
611 ADVERSE EVENT 9 0.0001
612 NEUTROPHIL COUNT INCREASED 1 0.0001
613 INITIAL INSOMNIA 1 0.0001
614 MOBILITY DECREASED 7 0.0001
615 EXPOSURE DURING PREGNANCY 6 0.0001
616 RESPIRATORY FAILURE 7 0.0001
617 DRUG-INDUCED LIVER INJURY 3 0.0001
618 DYSPHAGIA 9 0.0001
619 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
620 METABOLIC ACIDOSIS 3 0.0001
621 DRUG INTOLERANCE 9 0.0001
622 SWELLING FACE 6 0.0001
623 PRODUCT PRESCRIBING ISSUE 2 0.0001
624 WOUND INFECTION 1 0.0001
625 HAEMATOCHEZIA 5 0.0001
626 DENTAL CARIES 1 0.0001
627 LIP SWELLING 3 0.0001
628 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
629 SEPSIS 10 0.0001
630 PNEUMONIA 29 0.0001
631 SOMNOLENCE 18 0.0001
632 ORAL PAIN 2 0.0001
633 SKIN INFECTION 1 0.0001
634 BLOOD CALCIUM DECREASED 1 0.0001
635 EYE INFECTION 1 0.0001
636 MITRAL VALVE INCOMPETENCE 1 0.0001
637 MICTURITION URGENCY 1 0.0001
638 SKIN DISCOLOURATION 4 0.0001
639 METASTASES TO LUNG 1 0.0001
640 MADAROSIS 1 0.0001
641 ELECTROLYTE IMBALANCE 1 0.0001
642 POST PROCEDURAL HAEMORRHAGE 1 0.0001
643 RASH 37 0.0001
644 COVID-19 PNEUMONIA 1 0.0001
645 OCULAR HYPERAEMIA 4 0.0001
646 BLOOD IRON DECREASED 1 0.0001
647 THYROID CANCER 1 0.0001
648 SKIN EXFOLIATION 7 0.0001
649 HYPERGLYCAEMIA 3 0.0001
650 NO THERAPEUTIC RESPONSE 1 0.0001
651 RESTLESSNESS 3 0.0001
652 AGITATION 6 0.0001
653 RESPIRATORY DEPRESSION 1 0.0001
654 MUSCLE SPASTICITY 1 0.0001
655 NASOPHARYNGITIS 15 0.0001
656 INJECTION SITE MASS 3 0.0001
657 ABNORMAL WEIGHT GAIN 1 0.0001
658 ABASIA 2 0.0001
659 HAIR COLOUR CHANGES 1 0.0001
660 TOOTH EXTRACTION 1 0.0001
661 DRUG INEFFECTIVE 105 0.0001
662 HOT FLUSH 6 0.0001
663 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
664 HAEMATEMESIS 2 0.0001
665 INSOMNIA 21 0.0001
666 HOSPITALISATION 12 0.0001
667 MYDRIASIS 1 0.0001
668 INFUSION SITE PAIN 1 0.0001
669 UNRESPONSIVE TO STIMULI 2 0.0001
670 INJECTION SITE INDURATION 1 0.0001
671 ABDOMINAL DISTENSION 8 0.0001
672 ORAL CANDIDIASIS 1 0.0001
673 TOOTH INFECTION 1 0.0001
674 PULMONARY CONGESTION 1 0.0001
675 ADVERSE REACTION 1 0.0001
676 DRY SKIN 10 0.0001
677 QUALITY OF LIFE DECREASED 1 0.0001
678 DRUG EFFECT DECREASED 4 0.0001
679 DRUG TOXICITY 1 0.0001
680 PERIPHERAL COLDNESS 1 0.0001
681 RESPIRATORY DISTRESS 2 0.0001
682 ABNORMAL DREAMS 2 0.0001
683 ANAPHYLACTIC REACTION 4 0.0001
684 MENTAL STATUS CHANGES 2 0.0001
685 ORAL DISCOMFORT 1 0.0001
686 POLLAKIURIA 3 0.0001
687 OXYGEN SATURATION DECREASED 4 0.0001
688 INJURY 5 0.0001
689 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
690 SLEEP DISORDER 5 0.0001
691 HEPATOCELLULAR INJURY 1 0.0001
692 BRONCHOSPASM 1 0.0001
693 PARALYSIS 1 0.0001
694 ACCIDENTAL UNDERDOSE 1 0.0001
695 PARAESTHESIA ORAL 1 0.0001
696 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
697 CONSTIPATION 15 0.0001
698 LIVER FUNCTION TEST ABNORMAL 2 0.0001
699 ILL-DEFINED DISORDER 4 0.0001
700 DEVICE FAILURE 1 0.0001
701 PRURITUS 25 0.0001
702 OROPHARYNGEAL PAIN 6 0.0001
703 MUSCULOSKELETAL CHEST PAIN 1 0.0001
704 ANKLE FRACTURE 1 0.0001
705 WEIGHT DECREASED 18 0.0001
706 LUNG INFECTION 1 0.0001
707 BONE DENSITY DECREASED 2 0.0001
708 ERYTHEMA 13 0.0001
709 RESPIRATORY TRACT CONGESTION 1 0.0001
710 HALLUCINATION, AUDITORY 1 0.0001
711 LOSS OF CONSCIOUSNESS 8 0.0001
712 LACTIC ACIDOSIS 2 0.0001
713 MUSCLE TIGHTNESS 1 0.0001
714 BLOOD POTASSIUM INCREASED 1 0.0001
715 MALAISE 27 0.0001
716 MANIA 1 0.0001
717 VENTRICULAR TACHYCARDIA 1 0.0001
718 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
719 CYTOMEGALOVIRUS INFECTION 1 0.0001
720 FUNGAL INFECTION 2 0.0001
721 LEUKOPENIA 3 0.0001
722 ANXIETY 17 0.0001
723 BLOOD UREA INCREASED 1 0.0001
724 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
725 CIRCULATORY COLLAPSE 1 0.0001
726 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
727 VISION BLURRED 8 0.0001
728 MULTI-ORGAN FAILURE 1 0.0001
729 DELIRIUM 2 0.0001
730 DEVICE USE ISSUE 1 0.0001
731 COVID-19 10 0.0001
732 DEPRESSED MOOD 3 0.0001
733 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
734 HEAD DISCOMFORT 1 0.0001
735 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
736 DIARRHOEA 36 0.0001
737 OEDEMA 3 0.0001
738 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
739 MUSCLE SPASMS 10 0.0001
740 DYSURIA 2 0.0001
741 BLOOD GLUCOSE ABNORMAL 1 0.0001
742 FALL 18 0.0001
743 BRONCHITIS 4 0.0001
744 HEPATIC STEATOSIS 1 0.0001
745 EPISTAXIS 4 0.0001
746 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
747 HEPATIC CIRRHOSIS 1 0.0001
748 BLOOD SODIUM DECREASED 1 0.0001
749 DEHYDRATION 7 0.0001
750 FEELING JITTERY 1 0.0001
751 SLEEP APNOEA SYNDROME 1 0.0001
752 LOWER LIMB FRACTURE 1 0.0001
753 PERIPHERAL SWELLING 8 0.0001
754 ABDOMINAL PAIN 12 0.0001
755 DYSTONIA 1 0.0001
756 EAR PAIN 1 0.0001
757 CHOKING 1 0.0001
758 ORAL HERPES 1 0.0001
759 KIDNEY INFECTION 1 0.0001
760 SINUS DISORDER 1 0.0001
761 DISORIENTATION 2 0.0001
762 HEART RATE INCREASED 5 0.0001
763 SYNCOPE 5 0.0000
764 JOINT SWELLING 6 0.0000
765 HEADACHE 31 0.0000
766 PLEURAL EFFUSION 3 0.0000
767 OEDEMA PERIPHERAL 6 0.0000
768 DISCOMFORT 3 0.0000
769 OSTEOPOROSIS 2 0.0000
770 ASTHENIA 18 0.0000
771 INTENTIONAL DRUG MISUSE 1 0.0000
772 DERMATITIS 1 0.0000
773 GAIT DISTURBANCE 9 0.0000
774 PLATELET COUNT DECREASED 5 0.0000
775 URINARY TRACT INFECTION 8 0.0000
776 INTENTIONAL OVERDOSE 3 0.0000
777 IRRITABLE BOWEL SYNDROME 1 0.0000
778 LIVER FUNCTION TEST INCREASED 1 0.0000
779 HYPOACUSIS 2 0.0000
780 POOR QUALITY SLEEP 1 0.0000
781 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
782 VAGINAL HAEMORRHAGE 2 0.0000
783 SEPTIC SHOCK 2 0.0000
784 PRODUCT DISPENSING ERROR 1 0.0000
785 MUSCULOSKELETAL STIFFNESS 4 0.0000
786 APPLICATION SITE PAIN 1 0.0000
787 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
788 LIVER DISORDER 2 0.0000
789 THROMBOCYTOPENIA 5 0.0000
790 RASH PAPULAR 1 0.0000
791 MUSCULAR WEAKNESS 5 0.0000
792 SHOCK 1 0.0000
793 HYPOKALAEMIA 2 0.0000
794 PERICARDIAL EFFUSION 1 0.0000
795 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
796 BLOOD GLUCOSE INCREASED 8 0.0000
797 PRODUCT PRESCRIBING ERROR 1 0.0000
798 COLORECTAL CANCER 2 0.0000
799 PRODUCTIVE COUGH 2 0.0000
800 BLOOD GLUCOSE DECREASED 2 0.0000
801 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
802 INFECTION 6 0.0000
803 NEURALGIA 1 0.0000
804 INJECTION SITE URTICARIA 1 0.0000
805 VISUAL IMPAIRMENT 5 0.0000
806 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
807 DRY EYE 2 0.0000
808 CELLULITIS 2 0.0000
809 UNEVALUABLE EVENT 3 0.0000
810 ACNE 3 0.0000
811 DEPRESSION 9 0.0000
812 PRODUCT COMPLAINT 1 0.0000
813 THERAPY CESSATION 2 0.0000
814 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
815 ANAPHYLACTIC SHOCK 1 0.0000
816 SKIN ULCER 1 0.0000
817 NO ADVERSE EVENT 7 0.0000
818 DIPLOPIA 1 0.0000
819 NERVOUSNESS 2 0.0000
820 HAEMORRHAGE 4 0.0000
821 GASTRITIS 1 0.0000
822 PANCREATITIS 2 0.0000
823 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
824 FATIGUE 29 0.0000
825 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
826 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
827 LIMB INJURY 1 0.0000
828 NAUSEA 29 0.0000
829 TREATMENT NONCOMPLIANCE 2 0.0000
830 CONDITION AGGRAVATED 11 0.0000
831 PROCEDURAL PAIN 1 0.0000
832 FEELING COLD 1 0.0000
833 BLISTER 2 0.0000
834 EYE IRRITATION 2 0.0000
835 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
836 BACK PAIN 8 0.0000
837 PRODUCT STORAGE ERROR 3 0.0000
838 ACUTE MYOCARDIAL INFARCTION 1 0.0000
839 TACHYCARDIA 3 0.0000
840 GASTROINTESTINAL DISORDER 3 0.0000
841 DEVICE ISSUE 3 0.0000
842 RESPIRATORY DISORDER 1 0.0000
843 ADVERSE DRUG REACTION 3 0.0000
844 FEELING ABNORMAL 8 0.0000
845 BLOOD POTASSIUM DECREASED 1 0.0000
846 PREMATURE BABY 1 0.0000
847 LACRIMATION INCREASED 1 0.0000
848 EMOTIONAL DISTRESS 4 0.0000
849 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
850 THERAPEUTIC RESPONSE DECREASED 2 0.0000
851 VERTIGO 2 0.0000
852 EPILEPSY 1 0.0000
853 PAIN 20 0.0000
854 CHEST PAIN 6 0.0000
855 SWELLING 3 0.0000
856 NERVOUS SYSTEM DISORDER 1 0.0000
857 MIGRAINE 3 0.0000
858 CYSTITIS 1 0.0000
859 STAPHYLOCOCCAL INFECTION 1 0.0000
860 BLOOD PRESSURE DECREASED 2 0.0000
861 SKIN DISORDER 1 0.0000
862 HYPOTENSION 6 0.0000
863 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
864 HAEMOGLOBIN DECREASED 3 0.0000
865 HAEMATURIA 1 0.0000
866 DEATH 25 0.0000
867 BURNING SENSATION 2 0.0000
868 HYPERKALAEMIA 1 0.0000
869 HEART RATE DECREASED 1 0.0000
870 LYMPHADENOPATHY 1 0.0000
871 THERAPY INTERRUPTED 2 0.0000
872 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
873 PANIC ATTACK 1 0.0000
874 HEPATIC FUNCTION ABNORMAL 1 0.0000
875 DYSPNOEA EXERTIONAL 1 0.0000
876 ASTHMA 3 0.0000
877 ARTHRALGIA 11 0.0000
878 DIABETES MELLITUS 2 0.0000
879 PALPITATIONS 3 0.0000
880 CHILLS 3 0.0000
881 ALOPECIA 5 0.0000
882 DISEASE PROGRESSION 3 0.0000
883 CARDIAC FAILURE 2 0.0000
884 CONFUSIONAL STATE 4 0.0000
885 BLINDNESS 1 0.0000
886 CARDIAC ARREST 2 0.0000
887 INJECTION SITE ERYTHEMA 3 0.0000
888 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
889 ROAD TRAFFIC ACCIDENT 1 0.0000
890 PAIN IN EXTREMITY 7 0.0000
891 HYPERHIDROSIS 3 0.0000
892 RECTAL HAEMORRHAGE 1 0.0000
893 ANGIOEDEMA 1 0.0000
894 PULMONARY OEDEMA 1 0.0000
895 THERAPY NON-RESPONDER 1 0.0000
896 BLOOD CHOLESTEROL INCREASED 1 0.0000
897 COMA 1 0.0000
898 MULTIPLE SCLEROSIS 1 0.0000
899 ATRIAL FIBRILLATION 2 0.0000
900 DYSPEPSIA 2 0.0000
901 DIZZINESS 10 0.0000
902 HYPOAESTHESIA 3 0.0000
903 FLUSHING 2 0.0000
904 INJECTION SITE PAIN 6 0.0000
905 INFLAMMATION 1 0.0000
906 MUSCULOSKELETAL PAIN 1 0.0000
907 SPEECH DISORDER 1 0.0000
908 DISTURBANCE IN ATTENTION 1 0.0000
909 RASH PRURITIC 1 0.0000
910 ARTHROPATHY 1 0.0000
911 PANCYTOPENIA 1 0.0000
912 TOXICITY TO VARIOUS AGENTS 3 0.0000
913 HYPONATRAEMIA 1 0.0000
914 EYE PAIN 1 0.0000
915 WHEEZING 1 0.0000
916 CATARACT 1 0.0000
917 SUICIDE ATTEMPT 1 0.0000
918 AMNESIA 1 0.0000
919 PRODUCT DOSE OMISSION 1 0.0000
920 BLOOD CREATININE INCREASED 1 0.0000
921 INFUSION RELATED REACTION 1 0.0000
922 RENAL FAILURE 2 0.0000
923 MEMORY IMPAIRMENT 2 0.0000
924 HYPERTENSION 3 0.0000
925 ACUTE KIDNEY INJURY 2 0.0000
926 INJECTION SITE SWELLING 1 0.0000
927 DRUG INTERACTION 2 0.0000
928 CARDIAC FAILURE CONGESTIVE 1 0.0000
929 PROSTATE CANCER 1 0.0000
930 THROMBOSIS 1 0.0000
931 DYSPNOEA 7 0.0000
932 DRY MOUTH 1 0.0000
933 INFLUENZA LIKE ILLNESS 1 0.0000
934 DRUG DOSE OMISSION 2 0.0000
935 DRUG ABUSE 1 0.0000
936 RENAL IMPAIRMENT 1 0.0000
937 CEREBROVASCULAR ACCIDENT 2 0.0000
938 MYALGIA 2 0.0000
939 CARDIAC DISORDER 1 0.0000
940 NEUROPATHY PERIPHERAL 1 0.0000
941 NEUTROPENIA 1 0.0000
942 ANAEMIA 1 0.0000